Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Revenue (2019 - 2025)

AdaptHealth has reported Revenue over the past 7 years, most recently at $846.3 million for Q4 2025.

  • Quarterly results put Revenue at $846.3 million for Q4 2025, down 1.21% from a year ago — trailing twelve months through Dec 2025 was $3.2 billion (changed 0.49% YoY), and the annual figure for FY2025 was $3.2 billion, changed 0.49%.
  • Revenue for Q4 2025 was $846.3 million at AdaptHealth, up from $820.3 million in the prior quarter.
  • Over the last five years, Revenue for AHCO hit a ceiling of $858.2 million in Q4 2023 and a floor of $482.1 million in Q1 2021.
  • Median Revenue over the past 5 years was $786.4 million (2022), compared with a mean of $756.6 million.
  • Biggest five-year swings in Revenue: surged 165.82% in 2021 and later fell 1.84% in 2025.
  • AdaptHealth's Revenue stood at $702.1 million in 2021, then increased by 11.13% to $780.3 million in 2022, then increased by 9.99% to $858.2 million in 2023, then decreased by 0.19% to $856.6 million in 2024, then dropped by 1.21% to $846.3 million in 2025.
  • The last three reported values for Revenue were $846.3 million (Q4 2025), $820.3 million (Q3 2025), and $800.4 million (Q2 2025) per Business Quant data.